シーケンスキットの世界市場

シーケンスキットの世界市場は2030年までに192億米ドルに達する見込み

2024年に129億米ドルと推定されるシーケンスキットの世界市場は、2024年から2030年にかけてCAGR 6.9%で成長し、2030年には192億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである核酸抽出と増幅は、CAGR 8.0％を記録し、分析期間終了までに125億米ドルに達すると予測されます。ライブラリー調製分野の成長率は、分析期間でCAGR 4.6%と推定されます。

米国市場は35億米ドルと推定、中国はCAGR11.0％で成長予測

米国のシーケンスキット市場は2024年に35億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに40億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3%と6.7%と予測されています。欧州では、ドイツがCAGR 4.5%で成長すると予測されています。

世界の「シーケンスキット」市場- 主要動向と促進要因のまとめ

なぜシーケンスキットがゲノミクスとプレシジョンメディシンの中心なのか？

シーケンスキットは、DNAおよびRNA解析ワークフローに不可欠なコンポーネントであり、遺伝物質の調製、増幅、デコードに必要な試薬やプロトコルを提供します。これらのキットは、全ゲノムシーケンス、標的遺伝子パネル、エピジェネティックプロファイリング、メタゲノミクスなどの幅広いアプリケーションをサポートします。臨床診断、腫瘍学研究、農業バイオテクノロジーのいずれにおいても、調査キットは複雑なワークフローを合理化し、一貫した結果を保証します。次世代シーケンサー（NGS）の進歩により、これらのキットの重要性がさらに高まっています。スループットの高いプラットフォームでは、何千ものサンプルを効率的に処理するために、高忠実度で汚染の少ない試薬が必要になるからです。さらに、消費者ゲノミクス、マイクロバイオーム検査、感染症サーベイランスの台頭により、シーケンスキットはエリート研究室だけでなく、分散型やポイントオブケア環境でも使用されるようになりました。その多用途性と遺伝子情報を解き明かす役割から、精密医療の時代には欠かせないものとなっています。

ライブラリー調製とPCRの革新がキットの進化を促す？

シーケンスキットは、基本的な試薬バンドルから、洗練された酵素最適化プラットフォームへと進化しています。ライブラリー調製キットの革新は、インプットDNAの必要量を減らし、自動化を可能にし、断片化したサンプルや劣化したサンプルをサポートするようになりました。PCRフリーのワークフローは増幅バイアスを最小化し、デュアルインデックスアダプターは精度を損なうことなく多重化を促進します。酵素の強化により、反応時間の短縮、特異性の向上、バックグラウンドノイズの最小化も実現しました。シングルセルシーケンスキット、ロングリードシーケンス試薬、メチル化特異的プレパレーションキットは、新たな生物学的領域へとこの技術の範囲を広げています。研究者が希少なバリアント、複雑な構造変異、細胞特異的な発現パターンを調査しようとする中、キットプロバイダーはオーダーメイドの高性能ケミストリーで対応しています。また、あらかじめ充填されたカートリッジ、凍結乾燥試薬、室温で安定したフォーマットにより、特にフィールド診断やモバイルラボ環境において、取り扱いや輸送が容易になっています。

規制と臨床統合はどのようにキットデザインを形成しているか？

シーケンシングが非侵襲的出生前検査（NIPT）、腫瘍学コンパニオン診断、病原体ゲノムトレーシングなど、規制対象の臨床診断に拡大するにつれ、シーケンスキットはより厳格な標準化と検証を受けています。開発メーカーは現在、FDA、CE-IVDR、その他の国の規制要件に準拠したIVDグレードのキットを開発しています。これには、事前に検証されたワークフロー、トレーサビリティ、試薬のロット間の一貫性などが含まれます。キットは、エンドツーエンドの互換性を確保し、ワークフローエラーを減らすために、シーケンスプラットフォームと共同開発されています。臨床検査情報システム（LIS）や自動リキッドハンドラーとの統合も、CLIA認定ラボや病院ベースのラボにとって重要になってきています。さらに、診療報酬に連動した診断が、開発者に効率改善とサンプルあたりのコスト削減を迫っています。これらの臨床アプリケーションは、調査ツールから医療ワークフローの重要で認証可能なコンポーネントへと変貌を遂げつつあり、より高い製造基準、より良い技術サポート、コンプライアンス文書化の重視を促しています。

シーケンスキット市場の世界的成長の原動力は？

世界のシーケンスキット市場の成長は、ゲノム研究費の増加、NGSの臨床導入、シーケンス化学の革新など、いくつかの要因によってもたらされます。米国、中国、英国、中東における国家的ゲノム研究イニシアチブの拡大により、高品質でコスト効率の高いキットへの需要が高まっています。腫瘍学、希少疾患診断、感染症サーベイランスにおけるシーケンスの統合（特にCOVID後）により、標準化され検証されたキットは臨床ラボにとって不可欠なものとなっています。学術機関、CRO、製薬会社はシーケンスに基づく探索プログラムを拡大しており、さまざまな特殊試薬キットを必要としています。一方、シングルセル、ロングリード、空間シーケンスの技術的進歩は、キットの性能と特異性の限界を押し上げつつあります。特に獣医学、農業、環境ゲノミクスの分野では、分散型検査が拡大し、フィールド対応のキットに対する新たな需要が生まれています。シーケンシングが生物学、医学、農業の中心的な柱となるにつれ、それを支えるキットのエコシステムも急速に拡大しています。

セグメント

タイプ（核酸抽出・増幅、ライブラリー調製、コントロール）、技術（NGS、サンガー）、用途（創薬、腫瘍学、生殖医療、感染症）、最終用途（製薬・バイオテクノロジー、病院・診断研究所、学術・研究機関、その他の最終用途）

調査対象企業の例（合計 32注目）

• Agilent Technologies, Inc.
• ArcherDX, Inc.
• Beckman Coulter, Inc.
• BGI Genomics Co., Ltd.
• Bioline（a Meridian Bioscience company）
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Fluidigm Corporation
• Illumina, Inc.
• New England Biolabs, Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Phase Genomics
• QIAGEN N.V.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Zymergen Inc.

関税影響係数

Global Industry Analystsは、本社国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Sequencing Kits Market to Reach US$19.2 Billion by 2030

The global market for Sequencing Kits estimated at US$12.9 Billion in the year 2024, is expected to reach US$19.2 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Nucleic Acid Extraction & Amplification, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$12.5 Billion by the end of the analysis period. Growth in the Library Preparation segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 11.0% CAGR

The Sequencing Kits market in the U.S. is estimated at US$3.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.0 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global "Sequencing Kits" Market - Key Trends & Drivers Summarized

Why Are Sequencing Kits Central to Genomics and Precision Medicine?

Sequencing kits are essential components in DNA and RNA analysis workflows, providing the reagents and protocols needed to prepare, amplify, and decode genetic material. These kits support a wide range of applications including whole genome sequencing, targeted gene panels, epigenetic profiling, and metagenomics. Whether used in clinical diagnostics, oncology research, or agricultural biotechnology, sequencing kits streamline complex workflows and ensure consistent results. Advances in next-generation sequencing (NGS) have made these kits even more critical, as higher throughput platforms require high-fidelity, low-contamination reagents to process thousands of samples efficiently. Additionally, with the rise of consumer genomics, microbiome testing, and infectious disease surveillance, sequencing kits are now used not only in elite research labs but also in decentralized and point-of-care settings. Their versatility and role in unlocking genetic information make them indispensable in the era of precision medicine.

Are Innovations in Library Prep and PCR Driving Kit Evolution?

Sequencing kits have evolved beyond basic reagent bundles into sophisticated, enzyme-optimized platforms. Innovations in library preparation kits have reduced input DNA requirements, enabled automation, and supported fragmented or degraded samples. PCR-free workflows are now available to minimize amplification bias, while dual-index adapters enhance multiplexing without compromising accuracy. Enzyme enhancements have also reduced reaction times, increased specificity, and minimized background noise. Single-cell sequencing kits, long-read sequencing reagents, and methylation-specific prep kits are expanding the technology’s reach into new biological domains. As researchers seek to study rare variants, complex structural variations, and cell-specific expression patterns, kit providers are responding with tailored, high-performance chemistry. Pre-loaded cartridges, lyophilized reagents, and room-temperature-stable formats are also enabling easier handling and shipping, especially in field diagnostics and mobile lab environments.

How Are Regulation and Clinical Integration Reshaping Kit Design?

As sequencing expands into regulated clinical diagnostics-such as non-invasive prenatal testing (NIPT), oncology companion diagnostics, and pathogen genome tracing-sequencing kits are undergoing stricter standardization and validation. Manufacturers are now developing IVD-grade kits compliant with FDA, CE-IVDR, and other national regulatory requirements. This includes pre-validated workflows, traceability, and lot-to-lot consistency in reagents. Kits are being co-developed with sequencing platforms to ensure end-to-end compatibility and reduce workflow errors. Integration with laboratory information systems (LIS) and automated liquid handlers is also becoming critical for CLIA-certified and hospital-based labs. Furthermore, reimbursement-linked diagnostics are pressuring developers to improve efficiency and reduce cost per sample. These clinical applications are transforming sequencing kits from research tools into critical, certifiable components of medical workflows, prompting higher manufacturing standards, better technical support, and increased focus on compliance documentation.

What’s Fueling Global Growth in the Sequencing Kits Market?

The growth in the global sequencing kits market is driven by several factors including rising genomic research funding, clinical adoption of NGS, and innovations in sequencing chemistry. Expanding national genomics initiatives across the U.S., China, UK, and Middle East are generating bulk demand for high-quality, cost-efficient kits. The integration of sequencing in oncology, rare disease diagnosis, and infectious disease surveillance-particularly post-COVID-has made standardized, validated kits essential for clinical labs. Academic institutions, CROs, and pharma companies are scaling up sequencing-based discovery programs, requiring a range of specialized reagent kits. Meanwhile, technological advancements in single-cell, long-read, and spatial sequencing are pushing the limits of kit performance and specificity. Growth of decentralized testing, especially in veterinary, agricultural, and environmental genomics, is creating new demand for field-compatible kits. As sequencing becomes a core pillar of biology, medicine, and agriculture, the supporting kit ecosystem is expanding rapidly to keep pace.

SCOPE OF STUDY:

The report analyzes the Sequencing Kits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Nucleic Acid Extraction & Amplification, Library Preparation, Control); Technology (NGS, Sanger); Application (Drug Discovery, Oncology, Reproductive Health, Infectious Diseases); End-Use (Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Agilent Technologies, Inc.
• ArcherDX, Inc.
• Beckman Coulter, Inc.
• BGI Genomics Co., Ltd.
• Bioline (a Meridian Bioscience company)
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Fluidigm Corporation
• Illumina, Inc.
• New England Biolabs, Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Phase Genomics
• QIAGEN N.V.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Zymergen Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Sequencing Kits - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Widespread Adoption of Precision Medicine and Genomics Propels Growth in Sequencing Kit Demand
  • Rapid Decline in NGS Costs Expands Access and Drives Use of Sequencing Kits Across Research and Clinical Settings
  • Increased Focus on Infectious Disease Surveillance and Pathogen Genotyping Strengthens Business Case for Rapid Kits
  • Surge in Genetic Testing for Ancestry and Wellness Drives Consumer-Focused Sequencing Kit Innovations
  • Advancements in Single-Cell Sequencing Technologies Accelerate Need for High-Fidelity, Low-Input Kits
  • Regulatory Push for Companion Diagnostics and Targeted Therapies Expands Market for Clinical-Grade Sequencing Kits
  • Growing Cancer Genomics Programs Globally Spurs Demand for Oncology-Specific Sequencing Solutions
  • Automation in Laboratory Workflows Drives Adoption of Pre-Configured and Ready-to-Use Sequencing Kits
  • Expansion of Biobanking and Population Genomics Initiatives Creates New Opportunities for Large-Scale Sequencing
  • Rise in Agricultural Genomics and CRISPR Research Sustains Demand for High-Throughput Sequencing Kits
  • Strategic Collaborations Between Biotech and Diagnostic Companies Generate Pipeline for Custom Sequencing Kits
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Sequencing Kits Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Sequencing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Nucleic Acid Extraction & Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Nucleic Acid Extraction & Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Nucleic Acid Extraction & Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pharmaceutical & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Pharmaceutical & Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for NGS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Sanger by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Sanger by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Sanger by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• JAPAN
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• CHINA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 80: China Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• EUROPE
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Sequencing Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• FRANCE
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 107: France Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• GERMANY
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 143: UK Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Sequencing Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• INDIA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 218: India Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Sequencing Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Sequencing Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• AFRICA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030

IV. COMPETITION